en Experimental Neurobiology

Cited by CrossRef (6)

  1. Yuting Zou, Runan Yang, Lin Li, Xiumei Xu, Shangdong Liang. Purinergic signaling: a potential therapeutic target for depression and chronic pain. Purinergic Signalling 2023;19:163
    https://doi.org/10.1007/s11302-021-09801-x
  2. Juliana Maia Teixeira, Carlos Amílcar Parada, Cláudia Herrera Tambeli. P2X3 and P2X2/3 receptors activation induces articular hyperalgesia by an indirect sensitization of the primary afferent nociceptor in the rats’ knee joint. European Journal of Pharmacology 2020;879:173054
    https://doi.org/10.1016/j.ejphar.2020.173054
  3. Elina KC, Jaisan Islam, Hyong Kyu Kim, Young Seok Park. GFAP-NpHR mediated optogenetic inhibition of trigeminal nucleus caudalis attenuates hypersensitive behaviors and thalamic discharge attributed to infraorbital nerve constriction injury. J Headache Pain 2023;24
    https://doi.org/10.1186/s10194-023-01669-z
  4. Y.F. Zhao, A. Verkhratsky, Y. Tang, P. Illes. Astrocytes and major depression: The purinergic avenue. Neuropharmacology 2022;220:109252
    https://doi.org/10.1016/j.neuropharm.2022.109252
  5. Barbora Salcman, Karen Affleck, Silvia Bulfone-Paus. P2X Receptor-Dependent Modulation of Mast Cell and Glial Cell Activities in Neuroinflammation. Cells 2021;10:2282
    https://doi.org/10.3390/cells10092282
  6. Tianyi Wang, Liu Liu, Dongzhe Song, Dingming Huang. Emerging roles of lncRNAs in the pathogenesis, diagnosis, and treatment of trigeminal neuralgia. 2022;50:1013
    https://doi.org/10.1042/BST20220070